Boland Michael V, Quigley Harry A
Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
J Glaucoma. 2007 Jun-Jul;16(4):406-18. doi: 10.1097/IJG.0b013e31806540a1.
Decades of epidemiologic research into open-angle glaucoma have elucidated several risk factors related in some way to the disease. As more and more risk factors are identified, however, assessing their individual and collective contributions in a particular patient is becoming increasingly complicated. To help organize our knowledge of risk in glaucoma we first review some concepts of risk and then propose a scheme that places known risk factors into categories (state of the individual, ocular anatomy and physiology, signs of disease, non-glaucoma medications, and personal behaviors) and also indicates how each factor interacts with disease (incidence, prevalence, progression, therapy.) We also describe methods for using risk factors in clinical practice and describe ways that a large and complex body of knowledge can be applied to individual patients.
数十年来,针对开角型青光眼的流行病学研究已阐明了一些与该疾病存在某种关联的风险因素。然而,随着越来越多的风险因素被识别出来,评估它们在特定患者中的个体和共同作用正变得日益复杂。为了梳理我们对青光眼风险的认识,我们首先回顾一些风险概念,然后提出一个方案,将已知的风险因素归类(个体状态、眼部解剖与生理、疾病体征、非青光眼药物以及个人行为),并指出每个因素如何与疾病相互作用(发病率、患病率、进展、治疗)。我们还描述了在临床实践中使用风险因素的方法,并阐述了如何将大量复杂的知识应用于个体患者。